| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| TAE684 (NVP-TAE684); TAE684 (NVP-TAE684) | CFN60203 | 761439-42-3 | C30H40ClN7O3S = 614.2 | 5mg | QQ客服：1413575084 |
| Ataluren (PTC124) ; Ataluren (PTC124) | CFN60204 | 775304-57-9 | C15H9FN2O3 = 284.24 | 5mg | QQ客服：3257982914 |
| Dinaciclib (SCH727965); Dinaciclib (SCH727965) | CFN60205 | 779353-01-4 | C21H28N6O2 = 396.49 | 5mg | QQ客服：3257982914 |
| ICG-001; ICG-001 | CFN60206 | 780757-88-2 | C33H32N4O4 = 548.63 | 5mg | QQ客服：215959384 |
| 奥巴克拉甲磺酸盐; Obatoclax Mesylate (GX15-070) | CFN60207 | 803712-79-0 | C20H19N3O.CH4O3S = 413.49 | 5mg | QQ客服：3257982914 |
| 罗沙司他; Roxadustat (FG-4592) | CFN60208 | 808118-40-3 | C19H16N2O5 = 352.34 | 5mg | QQ客服：2159513211 |
| R406 free base; R406 free base | CFN60209 | 841290-80-0 | C22H23FN6O5 = 470.45 | 5mg | QQ客服：1457312923 |
| R406; R406 | CFN60210 | 841290-81-1 | C22H23FN6O5.C6H6O3S = 628.63 | 5mg | QQ客服：1457312923 |
| AT7519; AT7519 | CFN60211 | 844442-38-2 | C16H17Cl2N5O2 = 382.24 | 5mg | QQ客服：2159513211 |
| A-769662; A-769662 | CFN60212 | 844499-71-4 | C20H12N2O3S = 360.39 | 5mg | QQ客服：2056216494 |
| RO4929097; RO4929097 | CFN60213 | 847925-91-1 | C22H20F5N3O3 = 469.4 | 5mg | QQ客服：1413575084 |
| 沙普替尼; Sapitinib (AZD8931) | CFN60214 | 848942-61-0 | C23H25ClFN5O3 = 473.93 | 5mg | QQ客服：215959384 |
| Foretinib (GSK1363089); Foretinib (GSK1363089) | CFN60215 | 849217-64-7 | C34H34F2N4O6 = 632.65 | 5mg | QQ客服：2159513211 |
| 卡博替尼; Cabozantinib (BMS-907351) | CFN60216 | 849217-68-1 | C28H24FN3O5 = 501.51 | 5mg | QQ客服：2056216494 |
| 替莫唑胺; Temozolomide | CFN60217 | 85622-93-1 | C6H6N6O2 = 194.15 | 5mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)